Drug
lamotrigine
Marketed as SUBVENITE.
Generic name
lamotrigine
Brand names
SUBVENITE
First FDA approval
2025-09-16
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA218879 | SUBVENITE | 2025-09-16 | OWP PHARMS |
Manufacturers
OWP PHARMS
Frequently asked questions
When was lamotrigine FDA approved?
Earliest FDA approval on record: 2025-09-16.
What brand names are sold as lamotrigine?
SUBVENITE.
Sources
Appeal a lamotrigine denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com